EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
International Stem Cell Corp. (ISCO) had EBIT Margin of -8.21% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.31M |
|
$-0.22M |
|
$0.95M |
|
$1.36M |
|
$2.50M |
|
$-0.19M |
|
$-0.03M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.19M |
|
$-0.16M |
|
8.00M |
|
8.00M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$3.81M |
|
$0.17M |
|
$1.32M |
|
$5.13M |
|
$5.05M |
|
-- |
|
$4.30M |
|
$9.35M |
|
$-4.22M |
|
$-4.85M |
|
$-4.22M |
|
8.00M |
|
| Cash Flow Statement Financials | |
$0.12M |
|
$-0.03M |
|
$-0.15M |
|
$0.99M |
|
$0.93M |
|
$-0.06M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.79% |
|
-8.21% |
|
|
EBIT Margin |
-8.21% |
-- |
|
-9.50% |
|
-9.50% |
|
$0.10M |
|
-- |
|
-- |
|
-- |
|
0.45 |
|
0.54 |
|
2.93 |
|
30.75 |
|
5.21% |
|
4.54% |
|
-4.29% |
|
5.22% |
|
$-0.53 |
|
$0.01 |
|
$0.02 |
|